Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
In re: "Celera Corporation Securities Litigation."
Case Number:
5:10-cv-02604
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- DiCello Levitt
- Gardy & Notis
- Glancy Prongay
- Jones Day
- King & Spalding
- Latham & Watkins
- Morrison Foerster
- Proskauer Rose
- Robbins Geller
- Robbins LLP
- Schneider Wallace
- Shearman & Sterling
Companies
Sectors & Industries:
-
September 02, 2014
Celera, PwC Hand Over $25M To Exit Investor Class Action
Celera Corp. and PricewaterhouseCoopers LLP agreed on Friday to pay nearly $25 million to settle a shareholder class action in California federal court claiming Celera made overly optimistic revenue forecasts and covered up billing problems.
-
February 26, 2014
Celera Shareholders Win Class Cert.
A California federal judge on Tuesday certified the class in a shareholder suit accusing medical diagnostics company Celera Corp. of covering up billing problems and making overly optimistic revenue forecasts, ruling that the class met predominance and superiority requirements needed for certification.
-
September 05, 2012
Celera Can't Duck Shareholder Suit Over Financial Reports
A California federal judge on Tuesday denied Celera Corp.'s bid to dismiss a putative shareholder class action over the medical diagnostics company's alleged financial misstatements, ruling the plaintiffs had provided enough evidence to allow their loss causation and intentional misstatement claims to go ahead.